Balentine LLC’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-13,245
Closed -$617K 628
2019
Q3
$617K Buy
13,245
+1,224
+10% +$56.9K 0.04% 49
2019
Q2
$628K Buy
12,021
+3,033
+34% +$178K 0.04% 51
2019
Q1
$620K Buy
+8,988
New +$603K 0.04% 49
2018
Q4
Sell
-59
Closed -$7K 441
2018
Q3
$7K Buy
+59
New +$6.66K ﹤0.01% 218
2018
Q1
Sell
-5,785
Closed -$634K 148
2017
Q4
$634K Buy
5,785
+481
+9% +$48K 0.05% 49
2017
Q3
$524K Buy
5,304
+38
+0.7% +$3.68K 0.04% 51
2017
Q2
$533K Buy
5,266
+347
+7% +$37.4K 0.05% 47
2017
Q1
$568K Buy
4,919
+5
+0.1% +$581 0.06% 38
2016
Q4
$590K Buy
4,914
+370
+8% +$41K 0.06% 31
2016
Q3
$510K Buy
4,544
+3,651
+409% +$421K 0.07% 36
2016
Q2
$111K Buy
893
+274
+44% +$33.1K 0.02% 104
2016
Q1
$70K Hold
619
0.02% 97
2015
Q4
$67K Sell
619
-165
-21% -$18.9K 0.01% 139
2015
Q3
$78K Hold
784
0.01% 119
2015
Q2
$89K Sell
784
-465
-37% -$56.4K 0.01% 101
2015
Q1
$131K Buy
+1,249
New +$133K 0.02% 76

Other funds holding CLB